Secondary Hyperaldosteronism

Overview


Plain-Language Overview

Secondary hyperaldosteronism is a condition where the body produces too much aldosterone, a hormone that controls salt and water balance. This condition affects the kidneys and the hormonal system that regulates blood pressure. When aldosterone levels are high, the body retains excess sodium and loses potassium, which can lead to high blood pressure and muscle weakness. The excess aldosterone is caused by an overactive renin-angiotensin system, often due to decreased blood flow to the kidneys. This condition can result from problems like kidney artery narrowing or heart failure. Managing this condition is important because it can cause serious complications related to blood pressure and electrolyte imbalances.

Clinical Definition

Secondary hyperaldosteronism is characterized by excessive secretion of aldosterone due to increased stimulation of the adrenal glands by elevated renin levels. The core pathology involves activation of the renin-angiotensin-aldosterone system (RAAS) secondary to decreased renal perfusion or sodium depletion. Common causes include renal artery stenosis, heart failure, cirrhosis, and nephrotic syndrome, all of which reduce effective circulating volume and trigger renin release. This leads to increased aldosterone production, causing sodium retention, potassium wasting, and hypertension. Unlike primary hyperaldosteronism, aldosterone elevation here is driven by high renin levels. Clinically, it is significant because it contributes to resistant hypertension and hypokalemia, requiring identification of the underlying cause for appropriate management.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.